SlideShare a Scribd company logo
1 of 45
[Cholinergic system] Model Questions and answers Dr.U.P.RathnakarMD.DIH.PGDHMwww.scribd.com
Q. Enumerate the different steps in cholinergic transmission, in the order of occurrence. Add a note on synthesis of acetylcholine in cholinergic nerve endings.	4 + 1 Cholinergic transmission Impulse conduction Arrival of impulse Synthesis, Storage & release of Ach by exocytosis Combination of Ach With receptors Postjunctional activity:  ,[object Object]
Inhibitory[IPSP]Termination of  	    Ach action 	    hydrolysis by true cholinesterase Synthesis of ACH ATP  + Acetate 	 + CoEn-A Acetylcholine + CoEn-A = Acetyl CoEn-A                              + [acetyl transferase] Choline
Q. Classify anti-cholinesterases with examples. Discuss the pharmacotherapy of organophosphorous poisoning.   3 + 2 Ans.  CLASSIFICATION Reversible anticholinesterases CarbamatesAcridine Tacrine. Physostigmine Neostigmine Pyridostigmine Edrophonium Ambenonium Demecarium Rivastigmine,  Donepezil,  Galantamine. Irreversible anticholinesterases Organophosphates	Carbamates EchothiophateCarbaryl* Parathion* 	Propoxur* Malathion* Diazinon* Tabun# Sarin# Soman# Ans.    ‘PHARMACOTHERAPY’ OF OP POISONING ,[object Object]
Signs and symptoms are due to excess of cholinergic activity resulting in excess of parasympathetic or sympathetic activity.
Antimuscarinic drug Atropine is the specific antidote[DOC]
Atropine 2mg i.v, repeated every 10 minutes until atropinization symptoms appear.
Maintenance dose continued for 2 weeks
Pralidoxime, cholinesterase activator, is administered for nicotinic adverse effects, after atropine. 1-2g slow i.v.
Pralidoxime is C.I. in carbamate poisoning
Diazepami.v. if convulsions are present
Other supportive measures,[object Object]
Increases uveo-scleral outflow
May also increase trabecular out flow,[object Object]
Q. Name two cholinesterases.  Mention differences between them.  1 + 2 Ans. Two cholinesterases Acetyl cholinesterase[true]        2.  Butyrylcholinesterase [pseudo] Differences
Write briefly on Edrophonium test.    	3  [Tensilon]Edrophonium test To aid diagnosis i.v.2 mg of edrophonium chloride->45 seconds -> 8 mg if the first dose is without effect ->Brief improvement in strength ->MG diagnosis To moderate treatment in patient already being treated and c/o muscle weakness i.v. 2 mg. Decrease in strength indicates cholinergic crisis [Overdose of anticholinesterases in tt]  Improvement signifies myasthenic crisis [Under dose of anticholinesterases in tt]
Q. Location of different subtypes of cholinoreceptors          2	 Ans   Location Receptor Gastric glands, Autonomic ganglia & CNS M1 SA node, AV node, Atrium, Ventricle, Auto receptors  M2 Visceral smooth muscle, Iris, Ciliary  muscle, Exocrine glands, Vascular endothelium. M3 CNS M4 M5 NM junction NM Autonomic ganglia, Adrenal medulla NN
 Q. Why neostigmine is preferred over physostigmine in the treatment of  myasthenia gravis?  						2 Ans.   Unlike physostigmine They have direct action on Nicotinic receptors at NM junction  -Hence augmentation of action Being quaternary compounds do not cross BBB –No CNS effects
Q. Rationale for use of Timolol in glaucoma   3 Ans It is a non-slectiveβ blocker. It blocks the β2 receptors in ciliary body and reduces the secretion of aqueous humor. Produce smooth and sustained fall in IOT No change in pupil size as with pilocarpine. Convenience of dosage-once or twice daily Less adverse effects It has systemic ADEs like worsening of bronchial asthma, CHF and bradycardia
Q. Treatment of Atropine poisoning     2 Ans Gastric lavage with KMNO4-if ingested Nursed in a dark, quite room Cold sponging Physostigmine-1-3 mg i.v/s.c General supportive measures[ i.v. fluids, diazepam, respiration]
Q. Explain the actions of atropine on the eye and CNS. Explain the therapeutic uses of atropine substitutes   1+4 Ans Atropine on eye- It competitively blocks M3 receptors in constrictor pupillaeand ciliary muscle and effect passive mydriasis& Cycloplegia. It also increases IOT and abolishes light reflex. Atropine on CNS It crosses BBB. It is a CNS stimulant. Depresses vestibular system. Blocks cholinergic activity in basal ganglia and reduces tremor and rigidity in parkinsonism High doses produce delirium and hallucinations. ……..See next slide for uses of atropine substitutes
Q. Therapeutic uses of atropine substitutes Ans Motion sickness-Scopolamine Mydriatics-Homatropine, tropicamide, cyclopentolate Preanesthetic-Glycopyrrolate Intestinal and renal colic-Dicyclomine COPD, bronchial asthma-ipratropium & tiotropium bromide Parkinsonism-trihexyphenydyl Bradyarrhythmias-Atropine
Q. Write briefly on cycloplegicmydriatics -3 Ans. Cycloplegicmydriatics are the drugs which paralyze ciliary muscles and constrictor pupillae Antimuscarinics like atrpoine competitively block M3 receptors in these sites and effect Cycloplegia, passive mydriasis and abolish light reflex Eg. Atropine, homoatropine, tropicamide, cyclopentolate Atropine is the longest acting[7days] & tropicamide is the shortest. They are used for fundus examination, refractory testing , to give rest to muscles of eye and to break iris adhesions alternatively with miotics
Q. Mention two drugs used in myesthenia gravis. How will you differentiate myastenic crisis from choloinergic crisis  1+4 Ans Drugs in MG Anticholinesterases-Eg. Neostigmine, Pyridostigmine Glucocorticoids-Prednisolone Immunosuppresants-Azathioprine, Cyclosporine Cholinergic and myasthenic crisis Differentiated by Edrophonium test i.v.2 mg of edrophonium chloride-> Decrease in strength indicates cholinergic crisis [Overdose of anticholinesterases in tt]  Improvement signifies myasthenic crisis [Under dose of anticholinesterases in tt]
Q. Mention any SIX drugs used in glaucoma. Explain the mechanism of  action of any  one drug             5 Drugs used in glaucoma Pilocarpine Timolol Latanaprost Acetazolamide Apraclonidine Mannitol     MOA of α2 agonists α 2 agonists primarily reduce secretion of aqueous humor by acting on the α 2 receptors on the ciliary body. Subsidiary action is their α 1action, constriction of ciliary blood vessels,reduction in the synthesis of aqueous humor
Q. Uses and adverse effects of neuromuscular blockers          5 Uses Ans. Surgical relaxation[Adsjuant to GA] Tracheal Intubation Control of Ventilation-to reduce chest wall resistance in pts on ventilators Treatment of Convulsions in epilepsy SCH - brief procedures – endotracheal intubation, laryngoscopy, esophagoscopy, reduction of fractures and dislocations. With ECT-to prevent convulsions & trauma Adverse effects Muscle Pain-Myalgias are a common postoperative complaint [SCh] Respiratory paralysis Flushing Fall in BP[dtc] Precipitation of asthma[dtc] Malignant hyperthermia[SCh] Increased Intraocular Pressure[SCh] Increased Intragastric Pressure[SCh] Hyperkalemia [SCh+burns etc.]
Mention any SIX antimuscarinic agents Mention one use for each                        5 Uses Antimuscarinics Atropine Scopolamine Homatropine Glycopyrrolate Benzhexol Ipratropium bromide OP poisoning Travel sickness Mydriatic for testing of errors of refraction Preanesthetic-antisecretory Parkinsonism As bronchodilator in COPD & Bronchial asthma
Q. List the differences between physostigmineand neostigmine-     2
Q. Explain the pharmacological basis for the following.    2 2. Pyridostigmine is used in myasthenia gravis 1. Atropine is contraindicated in patients with Glaucoma The intraocular tension tends to rise, especially in narrow angle glaucoma, as drainage of aqueous humor is compromised by crowding of the iris at angles Pyridostigmine is a reversible anti cholinesterase It inhibits the acetyl cholinesterase at neuromuscular junction and potentiates the action of Ach. More acetylcholine is made available to stimulate the less than normal no. of nicotinic receptors in myasthenia gravis. There by improves the muscle power, reduces fatigue. It requires less frequent dosing compared to neostigmine
Write briefly on  ‘Succinylcholine’5 Chemistry: Resembles Ach, quaternary compound MOA: It is a depolarizing neuromuscular blocker. Produces Phase I block by persistent depolarization of nicotinic receptor and phase II block by receptor desensitization. Duration is about five mts. PK: Not absorbed orally nor crosses BBB. Hydrolyzed by pseudocholinesterase. Resistant to true cholinesterase. ADEs: In those with variant pseudocholinesterase can produce succinylcholineapnoea. Along with fluorinated anesthetics, in susceptible individuals can produce malignant hyperthermia. Hyperkalaemiain those with trauma and burns DIs: Should not be mixed with thiopentone in the same syringe Uses: 1. Short procedures like endoscopies,  2. Fracture reduction 3. Tracheal intubation
Q. Enumerate the types & subtypes of cholinergic receptors. Mention the sites  where acetylcholine is theprincipal neurotransmitter.                                2+2=4 Types & subtypes Muscarinic M1, M2, M3, M4, M5 Nicotinic NN, NM Cholinergic sites M1: Autonomic Ganglia, Gastric  glands, CNS M2: SA node, AV node, atrium, ventricle,  M3: Visceral smooth muscle Iris, ciliary muscles, exocrine glands, vascular endothelium M4, M5 : CNS NN :Autonomic ganglia & adrenal medulla NM :Neuromuscular junction
MCQ-1   Reactivation of cholinesterase enzyme inhibited by the following agent does not involve hydrolysis A. Edrophonium			C.    Physostigmine B. Galantamine			D.   Neostigmine
MCQ   Anticholinergic which can be used to facilitate testing errors of refraction includes Dicyclomine Clidinium Oxybutynin Cyclopentolate
MCQ   Miotics include Anticholinesterases α1 Adrenergic agonists Ganglionic blockers		 Antimuscarinics
MCQ   Non-selective betablockers used in the pharmacotherapy of glaucoma includes Betaxolol Atenolol Timolol Esmolol
MCQ Preferred anticholinesterase used in the treatment of Belladona[Atropine] poisoning is Physostigmine Edrophonium Neostigmine			 Parathion
MCQ Phenylephrine instilled in eye produces: Mydriasis but no cycloplegia. Cycloplegia but no mydriasis Both mydriasis and cycloplegia. Neither mydriasis nor cycloplegia.
MCQ Following are the drugs instilled locally into the eye in glaucoma EXCEPT Timolol Dorzolamide Acetazolamide Dipivefrine
MCQ Following drugs can be used in organophosphorous poisoning EXCEPT Prolidoxime Atropine Diazepam Acetylcholine
MCQ Which of the following skeletal muscle relaxant is shortest acting D-tubocuraine Pancuronium Cisatra curium Succinyl choline
The cholinomimetic drug which is not an alkaloid Acetylcholine Muscarine Pilocarpine Arecoline
The antimuscarinic agent which has high affinity for receptors in urinary bladder and salivary gland Oxybutynin Ipratropium Pirenzepine Tropicamide
Parasympathomimetics produce- Miosis, bradycardia, bronchodilatation Mydriasis, bradycardia, bronchoconstriction Miosis, bradycardia, bronchoconstriction Miosis, tachycardia, bronchoconstriction
Neostigmine can be used in all the following conditions, except: Cholinergic crisis Myasthenia gravis Paralytic ileus Curare poisoning
Pralidoxime is a Non-selective muscarinic receptor blocker Selective M1 receptor blocker Cholinesterase enzyme reactivator Cholinomimetic alkaloid

More Related Content

What's hot

Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockersraj kumar
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugsNaser Tadvi
 
Adrenergic Antagonists
Adrenergic AntagonistsAdrenergic Antagonists
Adrenergic AntagonistsAmira Badr
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonistsLeul Mesfin
 
Cholinergic drugs ppt
Cholinergic drugs pptCholinergic drugs ppt
Cholinergic drugs pptpharma stuff
 
Adrenergic antagonists
Adrenergic antagonistsAdrenergic antagonists
Adrenergic antagonistskencha swathi
 
Drugs used for cough
Drugs used for coughDrugs used for cough
Drugs used for coughBPKIHS
 
CHOLINERGIC AGONISTS
CHOLINERGIC AGONISTSCHOLINERGIC AGONISTS
CHOLINERGIC AGONISTSkencha swathi
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersPranav Bansal
 
Acetylcholine
AcetylcholineAcetylcholine
AcetylcholineWali Khan
 
Anticholinesterases
AnticholinesterasesAnticholinesterases
AnticholinesterasesKanav Bhanot
 

What's hot (20)

Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockers
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Sympathomimetic Drugs
Sympathomimetic Drugs Sympathomimetic Drugs
Sympathomimetic Drugs
 
Adrenergic Antagonists
Adrenergic AntagonistsAdrenergic Antagonists
Adrenergic Antagonists
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonists
 
Cholinergic drugs ppt
Cholinergic drugs pptCholinergic drugs ppt
Cholinergic drugs ppt
 
Adrenergic antagonists
Adrenergic antagonistsAdrenergic antagonists
Adrenergic antagonists
 
Drugs used for cough
Drugs used for coughDrugs used for cough
Drugs used for cough
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
CHOLINERGIC AGONISTS
CHOLINERGIC AGONISTSCHOLINERGIC AGONISTS
CHOLINERGIC AGONISTS
 
ANTICHOLINESTERASE DRUGS
ANTICHOLINESTERASE DRUGSANTICHOLINESTERASE DRUGS
ANTICHOLINESTERASE DRUGS
 
centrally acting muscle relaxants
centrally acting muscle relaxantscentrally acting muscle relaxants
centrally acting muscle relaxants
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
 
Skeletal Muscle Relaxants
Skeletal Muscle RelaxantsSkeletal Muscle Relaxants
Skeletal Muscle Relaxants
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Anticholinesterases
AnticholinesterasesAnticholinesterases
Anticholinesterases
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 

Viewers also liked

Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul KunkulolAcetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul KunkulolRahul Kunkulol
 
Anticholinesterase
AnticholinesteraseAnticholinesterase
AnticholinesteraseBrian Piper
 
Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonistMBBS IMS MSU
 
Cholinergic system Class I
Cholinergic system Class ICholinergic system Class I
Cholinergic system Class IRathnakar U P
 
The Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIThe Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIJimmy Lu
 
Limbic system & approach to amnesia
Limbic system & approach to amnesiaLimbic system & approach to amnesia
Limbic system & approach to amnesiaAbhinav Srivastava
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugsDr Roohana Hasan
 
Cholinergic blockers
Cholinergic  blockersCholinergic  blockers
Cholinergic blockersraj kumar
 
La toxicity 2010_0
La toxicity 2010_0La toxicity 2010_0
La toxicity 2010_0AnaestHSNZ
 
pathophysiological changes in ckd patients for anaesthetic concern
pathophysiological changes in ckd patients for anaesthetic concernpathophysiological changes in ckd patients for anaesthetic concern
pathophysiological changes in ckd patients for anaesthetic concerndrshowketdar
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoningAmit Poudel
 
Anatomy of neuroaxial system final
Anatomy of neuroaxial system finalAnatomy of neuroaxial system final
Anatomy of neuroaxial system finaldr anurag giri
 
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs Karun Kumar
 
Atropine substitutes
Atropine substitutesAtropine substitutes
Atropine substitutesAaditya Udupa
 
Amikor a munkavállalód építi a cég márkáját
Amikor a munkavállalód építi a cég márkájátAmikor a munkavállalód építi a cég márkáját
Amikor a munkavállalód építi a cég márkájátFerenc Pécsi
 

Viewers also liked (20)

Mcq pharmacology
Mcq pharmacologyMcq pharmacology
Mcq pharmacology
 
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul KunkulolAcetylcholinesterase inhibitors : Dr Rahul Kunkulol
Acetylcholinesterase inhibitors : Dr Rahul Kunkulol
 
Anticholinesterase
AnticholinesteraseAnticholinesterase
Anticholinesterase
 
Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonist
 
Cholinergic system Class I
Cholinergic system Class ICholinergic system Class I
Cholinergic system Class I
 
2. cholinergic drugs 2012
2. cholinergic drugs 20122. cholinergic drugs 2012
2. cholinergic drugs 2012
 
The Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part IIIThe Models of Alzheimer's Disease Part III
The Models of Alzheimer's Disease Part III
 
Gen Prin Sp Class
Gen Prin Sp ClassGen Prin Sp Class
Gen Prin Sp Class
 
Sexual morality
Sexual moralitySexual morality
Sexual morality
 
Limbic system & approach to amnesia
Limbic system & approach to amnesiaLimbic system & approach to amnesia
Limbic system & approach to amnesia
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Cholinergic blockers
Cholinergic  blockersCholinergic  blockers
Cholinergic blockers
 
La toxicity 2010_0
La toxicity 2010_0La toxicity 2010_0
La toxicity 2010_0
 
Prolong apneu
Prolong apneuProlong apneu
Prolong apneu
 
pathophysiological changes in ckd patients for anaesthetic concern
pathophysiological changes in ckd patients for anaesthetic concernpathophysiological changes in ckd patients for anaesthetic concern
pathophysiological changes in ckd patients for anaesthetic concern
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoning
 
Anatomy of neuroaxial system final
Anatomy of neuroaxial system finalAnatomy of neuroaxial system final
Anatomy of neuroaxial system final
 
Cholinergic system and drugs
Cholinergic system and drugs Cholinergic system and drugs
Cholinergic system and drugs
 
Atropine substitutes
Atropine substitutesAtropine substitutes
Atropine substitutes
 
Amikor a munkavállalód építi a cég márkáját
Amikor a munkavállalód építi a cég márkájátAmikor a munkavállalód építi a cég márkáját
Amikor a munkavállalód építi a cég márkáját
 

Similar to Cholinergic system model questions & answers

Anti cholinergic drugs- AIMS PARA.pptx
Anti cholinergic drugs- AIMS PARA.pptxAnti cholinergic drugs- AIMS PARA.pptx
Anti cholinergic drugs- AIMS PARA.pptxRaviMundugaru1
 
Cholinergic drugs uses in Ophthalmology
Cholinergic drugs uses in Ophthalmology Cholinergic drugs uses in Ophthalmology
Cholinergic drugs uses in Ophthalmology DrAzmat Ali
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonistscoolboy101pk
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor BlockersUsmanKhalid135
 
Case cholinergic for recording.pptx
Case cholinergic for recording.pptxCase cholinergic for recording.pptx
Case cholinergic for recording.pptxHagerAttiya1
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugsJyoti Sharma
 
Parasympathomimetics ( Cholinergic Agonists).pptx
Parasympathomimetics ( Cholinergic Agonists).pptxParasympathomimetics ( Cholinergic Agonists).pptx
Parasympathomimetics ( Cholinergic Agonists).pptxssuserb040ce
 
Antimuscarinic Agents
Antimuscarinic AgentsAntimuscarinic Agents
Antimuscarinic Agentshareesh c
 
Anticholinergic pharmacology
Anticholinergic pharmacologyAnticholinergic pharmacology
Anticholinergic pharmacologyNunkoo Raj
 
antimuscarnic drug
antimuscarnic drugantimuscarnic drug
antimuscarnic drugIslam Home
 
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsNewer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsShubham Marbade
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents RABBI
 
Parasympathomimetic drugs
Parasympathomimetic  drugsParasympathomimetic  drugs
Parasympathomimetic drugsAmit Kumar
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agentsKirti Vadi
 
Pharmacol report2..
Pharmacol report2..Pharmacol report2..
Pharmacol report2..Brian Musalo
 

Similar to Cholinergic system model questions & answers (20)

Anti cholinergic drugs- AIMS PARA.pptx
Anti cholinergic drugs- AIMS PARA.pptxAnti cholinergic drugs- AIMS PARA.pptx
Anti cholinergic drugs- AIMS PARA.pptx
 
Cholinergic drugs uses in Ophthalmology
Cholinergic drugs uses in Ophthalmology Cholinergic drugs uses in Ophthalmology
Cholinergic drugs uses in Ophthalmology
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor Blockers
 
Case cholinergic for recording.pptx
Case cholinergic for recording.pptxCase cholinergic for recording.pptx
Case cholinergic for recording.pptx
 
L3 ans pharmacology 2017 2018
L3 ans pharmacology 2017 2018L3 ans pharmacology 2017 2018
L3 ans pharmacology 2017 2018
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Parasympathomimetics ( Cholinergic Agonists).pptx
Parasympathomimetics ( Cholinergic Agonists).pptxParasympathomimetics ( Cholinergic Agonists).pptx
Parasympathomimetics ( Cholinergic Agonists).pptx
 
Antimuscarinic Agents
Antimuscarinic AgentsAntimuscarinic Agents
Antimuscarinic Agents
 
Anticholinergic pharmacology
Anticholinergic pharmacologyAnticholinergic pharmacology
Anticholinergic pharmacology
 
antimuscarnic drug
antimuscarnic drugantimuscarnic drug
antimuscarnic drug
 
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholyticsNewer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
Newer Trends and Recent Advances in Parasympathomimetics and parasympatholytics
 
Anticholinergics
AnticholinergicsAnticholinergics
Anticholinergics
 
Antimuscarinic Agents
Antimuscarinic Agents Antimuscarinic Agents
Antimuscarinic Agents
 
Fu
FuFu
Fu
 
Parasympathomimetic drugs
Parasympathomimetic  drugsParasympathomimetic  drugs
Parasympathomimetic drugs
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
NSAIDs.pptx
NSAIDs.pptxNSAIDs.pptx
NSAIDs.pptx
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
Pharmacol report2..
Pharmacol report2..Pharmacol report2..
Pharmacol report2..
 

More from Rathnakar U P

MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012Rathnakar U P
 
Gen Pharma Pharmaceutical Phase Bds
Gen Pharma Pharmaceutical Phase BdsGen Pharma Pharmaceutical Phase Bds
Gen Pharma Pharmaceutical Phase BdsRathnakar U P
 
Gen Pharmacology Intro Bds
Gen Pharmacology Intro BdsGen Pharmacology Intro Bds
Gen Pharmacology Intro BdsRathnakar U P
 
Environmental Pollutants
Environmental PollutantsEnvironmental Pollutants
Environmental PollutantsRathnakar U P
 

More from Rathnakar U P (6)

MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012MBBS antiarrhythmics 2012
MBBS antiarrhythmics 2012
 
Gen Pharma Pharmaceutical Phase Bds
Gen Pharma Pharmaceutical Phase BdsGen Pharma Pharmaceutical Phase Bds
Gen Pharma Pharmaceutical Phase Bds
 
Gen Pharmacology Intro Bds
Gen Pharmacology Intro BdsGen Pharmacology Intro Bds
Gen Pharmacology Intro Bds
 
Malaria 2003
Malaria 2003Malaria 2003
Malaria 2003
 
Drugs Of Abuse
Drugs Of AbuseDrugs Of Abuse
Drugs Of Abuse
 
Environmental Pollutants
Environmental PollutantsEnvironmental Pollutants
Environmental Pollutants
 

Recently uploaded

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 

Recently uploaded (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 

Cholinergic system model questions & answers

  • 1. [Cholinergic system] Model Questions and answers Dr.U.P.RathnakarMD.DIH.PGDHMwww.scribd.com
  • 2.
  • 3. Inhibitory[IPSP]Termination of Ach action hydrolysis by true cholinesterase Synthesis of ACH ATP + Acetate + CoEn-A Acetylcholine + CoEn-A = Acetyl CoEn-A + [acetyl transferase] Choline
  • 4.
  • 5. Signs and symptoms are due to excess of cholinergic activity resulting in excess of parasympathetic or sympathetic activity.
  • 6. Antimuscarinic drug Atropine is the specific antidote[DOC]
  • 7. Atropine 2mg i.v, repeated every 10 minutes until atropinization symptoms appear.
  • 9. Pralidoxime, cholinesterase activator, is administered for nicotinic adverse effects, after atropine. 1-2g slow i.v.
  • 10. Pralidoxime is C.I. in carbamate poisoning
  • 12.
  • 14.
  • 15. Q. Name two cholinesterases. Mention differences between them. 1 + 2 Ans. Two cholinesterases Acetyl cholinesterase[true] 2. Butyrylcholinesterase [pseudo] Differences
  • 16. Write briefly on Edrophonium test. 3  [Tensilon]Edrophonium test To aid diagnosis i.v.2 mg of edrophonium chloride->45 seconds -> 8 mg if the first dose is without effect ->Brief improvement in strength ->MG diagnosis To moderate treatment in patient already being treated and c/o muscle weakness i.v. 2 mg. Decrease in strength indicates cholinergic crisis [Overdose of anticholinesterases in tt] Improvement signifies myasthenic crisis [Under dose of anticholinesterases in tt]
  • 17. Q. Location of different subtypes of cholinoreceptors 2 Ans   Location Receptor Gastric glands, Autonomic ganglia & CNS M1 SA node, AV node, Atrium, Ventricle, Auto receptors M2 Visceral smooth muscle, Iris, Ciliary muscle, Exocrine glands, Vascular endothelium. M3 CNS M4 M5 NM junction NM Autonomic ganglia, Adrenal medulla NN
  • 18. Q. Why neostigmine is preferred over physostigmine in the treatment of myasthenia gravis? 2 Ans. Unlike physostigmine They have direct action on Nicotinic receptors at NM junction -Hence augmentation of action Being quaternary compounds do not cross BBB –No CNS effects
  • 19. Q. Rationale for use of Timolol in glaucoma 3 Ans It is a non-slectiveβ blocker. It blocks the β2 receptors in ciliary body and reduces the secretion of aqueous humor. Produce smooth and sustained fall in IOT No change in pupil size as with pilocarpine. Convenience of dosage-once or twice daily Less adverse effects It has systemic ADEs like worsening of bronchial asthma, CHF and bradycardia
  • 20. Q. Treatment of Atropine poisoning 2 Ans Gastric lavage with KMNO4-if ingested Nursed in a dark, quite room Cold sponging Physostigmine-1-3 mg i.v/s.c General supportive measures[ i.v. fluids, diazepam, respiration]
  • 21. Q. Explain the actions of atropine on the eye and CNS. Explain the therapeutic uses of atropine substitutes 1+4 Ans Atropine on eye- It competitively blocks M3 receptors in constrictor pupillaeand ciliary muscle and effect passive mydriasis& Cycloplegia. It also increases IOT and abolishes light reflex. Atropine on CNS It crosses BBB. It is a CNS stimulant. Depresses vestibular system. Blocks cholinergic activity in basal ganglia and reduces tremor and rigidity in parkinsonism High doses produce delirium and hallucinations. ……..See next slide for uses of atropine substitutes
  • 22. Q. Therapeutic uses of atropine substitutes Ans Motion sickness-Scopolamine Mydriatics-Homatropine, tropicamide, cyclopentolate Preanesthetic-Glycopyrrolate Intestinal and renal colic-Dicyclomine COPD, bronchial asthma-ipratropium & tiotropium bromide Parkinsonism-trihexyphenydyl Bradyarrhythmias-Atropine
  • 23. Q. Write briefly on cycloplegicmydriatics -3 Ans. Cycloplegicmydriatics are the drugs which paralyze ciliary muscles and constrictor pupillae Antimuscarinics like atrpoine competitively block M3 receptors in these sites and effect Cycloplegia, passive mydriasis and abolish light reflex Eg. Atropine, homoatropine, tropicamide, cyclopentolate Atropine is the longest acting[7days] & tropicamide is the shortest. They are used for fundus examination, refractory testing , to give rest to muscles of eye and to break iris adhesions alternatively with miotics
  • 24. Q. Mention two drugs used in myesthenia gravis. How will you differentiate myastenic crisis from choloinergic crisis 1+4 Ans Drugs in MG Anticholinesterases-Eg. Neostigmine, Pyridostigmine Glucocorticoids-Prednisolone Immunosuppresants-Azathioprine, Cyclosporine Cholinergic and myasthenic crisis Differentiated by Edrophonium test i.v.2 mg of edrophonium chloride-> Decrease in strength indicates cholinergic crisis [Overdose of anticholinesterases in tt] Improvement signifies myasthenic crisis [Under dose of anticholinesterases in tt]
  • 25. Q. Mention any SIX drugs used in glaucoma. Explain the mechanism of action of any one drug 5 Drugs used in glaucoma Pilocarpine Timolol Latanaprost Acetazolamide Apraclonidine Mannitol MOA of α2 agonists α 2 agonists primarily reduce secretion of aqueous humor by acting on the α 2 receptors on the ciliary body. Subsidiary action is their α 1action, constriction of ciliary blood vessels,reduction in the synthesis of aqueous humor
  • 26. Q. Uses and adverse effects of neuromuscular blockers 5 Uses Ans. Surgical relaxation[Adsjuant to GA] Tracheal Intubation Control of Ventilation-to reduce chest wall resistance in pts on ventilators Treatment of Convulsions in epilepsy SCH - brief procedures – endotracheal intubation, laryngoscopy, esophagoscopy, reduction of fractures and dislocations. With ECT-to prevent convulsions & trauma Adverse effects Muscle Pain-Myalgias are a common postoperative complaint [SCh] Respiratory paralysis Flushing Fall in BP[dtc] Precipitation of asthma[dtc] Malignant hyperthermia[SCh] Increased Intraocular Pressure[SCh] Increased Intragastric Pressure[SCh] Hyperkalemia [SCh+burns etc.]
  • 27. Mention any SIX antimuscarinic agents Mention one use for each 5 Uses Antimuscarinics Atropine Scopolamine Homatropine Glycopyrrolate Benzhexol Ipratropium bromide OP poisoning Travel sickness Mydriatic for testing of errors of refraction Preanesthetic-antisecretory Parkinsonism As bronchodilator in COPD & Bronchial asthma
  • 28. Q. List the differences between physostigmineand neostigmine- 2
  • 29. Q. Explain the pharmacological basis for the following. 2 2. Pyridostigmine is used in myasthenia gravis 1. Atropine is contraindicated in patients with Glaucoma The intraocular tension tends to rise, especially in narrow angle glaucoma, as drainage of aqueous humor is compromised by crowding of the iris at angles Pyridostigmine is a reversible anti cholinesterase It inhibits the acetyl cholinesterase at neuromuscular junction and potentiates the action of Ach. More acetylcholine is made available to stimulate the less than normal no. of nicotinic receptors in myasthenia gravis. There by improves the muscle power, reduces fatigue. It requires less frequent dosing compared to neostigmine
  • 30. Write briefly on ‘Succinylcholine’5 Chemistry: Resembles Ach, quaternary compound MOA: It is a depolarizing neuromuscular blocker. Produces Phase I block by persistent depolarization of nicotinic receptor and phase II block by receptor desensitization. Duration is about five mts. PK: Not absorbed orally nor crosses BBB. Hydrolyzed by pseudocholinesterase. Resistant to true cholinesterase. ADEs: In those with variant pseudocholinesterase can produce succinylcholineapnoea. Along with fluorinated anesthetics, in susceptible individuals can produce malignant hyperthermia. Hyperkalaemiain those with trauma and burns DIs: Should not be mixed with thiopentone in the same syringe Uses: 1. Short procedures like endoscopies, 2. Fracture reduction 3. Tracheal intubation
  • 31. Q. Enumerate the types & subtypes of cholinergic receptors. Mention the sites where acetylcholine is theprincipal neurotransmitter. 2+2=4 Types & subtypes Muscarinic M1, M2, M3, M4, M5 Nicotinic NN, NM Cholinergic sites M1: Autonomic Ganglia, Gastric glands, CNS M2: SA node, AV node, atrium, ventricle, M3: Visceral smooth muscle Iris, ciliary muscles, exocrine glands, vascular endothelium M4, M5 : CNS NN :Autonomic ganglia & adrenal medulla NM :Neuromuscular junction
  • 32. MCQ-1   Reactivation of cholinesterase enzyme inhibited by the following agent does not involve hydrolysis A. Edrophonium C. Physostigmine B. Galantamine D. Neostigmine
  • 33. MCQ   Anticholinergic which can be used to facilitate testing errors of refraction includes Dicyclomine Clidinium Oxybutynin Cyclopentolate
  • 34. MCQ   Miotics include Anticholinesterases α1 Adrenergic agonists Ganglionic blockers Antimuscarinics
  • 35. MCQ   Non-selective betablockers used in the pharmacotherapy of glaucoma includes Betaxolol Atenolol Timolol Esmolol
  • 36. MCQ Preferred anticholinesterase used in the treatment of Belladona[Atropine] poisoning is Physostigmine Edrophonium Neostigmine Parathion
  • 37. MCQ Phenylephrine instilled in eye produces: Mydriasis but no cycloplegia. Cycloplegia but no mydriasis Both mydriasis and cycloplegia. Neither mydriasis nor cycloplegia.
  • 38. MCQ Following are the drugs instilled locally into the eye in glaucoma EXCEPT Timolol Dorzolamide Acetazolamide Dipivefrine
  • 39. MCQ Following drugs can be used in organophosphorous poisoning EXCEPT Prolidoxime Atropine Diazepam Acetylcholine
  • 40. MCQ Which of the following skeletal muscle relaxant is shortest acting D-tubocuraine Pancuronium Cisatra curium Succinyl choline
  • 41. The cholinomimetic drug which is not an alkaloid Acetylcholine Muscarine Pilocarpine Arecoline
  • 42. The antimuscarinic agent which has high affinity for receptors in urinary bladder and salivary gland Oxybutynin Ipratropium Pirenzepine Tropicamide
  • 43. Parasympathomimetics produce- Miosis, bradycardia, bronchodilatation Mydriasis, bradycardia, bronchoconstriction Miosis, bradycardia, bronchoconstriction Miosis, tachycardia, bronchoconstriction
  • 44. Neostigmine can be used in all the following conditions, except: Cholinergic crisis Myasthenia gravis Paralytic ileus Curare poisoning
  • 45. Pralidoxime is a Non-selective muscarinic receptor blocker Selective M1 receptor blocker Cholinesterase enzyme reactivator Cholinomimetic alkaloid
  • 46. Following are the drugs effective in glaucoma, EXCEPT Dipivefrine Pilocarpine Timolol Dopamine
  • 47. Ipratropium bromide inhalation is preferred over atropine as bronchodilator because Does not affect the mucociliary secretion Not absorbed when it is swallowed Lack of CNS effects All of the above
  • 48. In which condition atropine is contraindicated? Heart block Peptic ulcer Hypertrophy of prostrate Bronchial asthma
  • 49. Post operative muscle soreness may be a side effect of the following neuromuscular blocker d-Tubocurarine Succinylcholine Pancuronium -Atracurium
  • 50. Which of the following drugs undergoes “Hoffmann” elimination. Succinylcholine Pancuronium Vecuronium -Atracurium
  • 51. Pseudocholinesterase can metabolize the following drugs, EXCEPT   Succinylcholine Procaine Acetylcholine Bethanechol
  • 52. Timolol reduces the intraocular pressure by Reducing the aqueous humor secretion Producing miosis Producing mydriasis Constricting the ciliary blood vessels
  • 53. The anticholinesterase agent not useful in Alzheimer’s disease Rivastigmine Donepezil Pyridostigmine Galantamine
  • 54. All of the following drugs are clinically used in myasthenia gravis EXCEPT Neostigmine Prednisolone Pyridostigmine Pilocarpine